|
"lu christine y"的相關文件
顯示項目 11-16 / 16 (共1頁)
1
每頁顯示[10|25|50]項目
| 國立成功大學 |
2015-10 |
Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan
|
Hsu, Jason C.; Cheng, Ching-Lan; Ross-Degnan, Dennis; Wagner, Anita K.; Zhang, Fang; Yang, Yea-Huei Kao; Liu, Li-Ling; Tai, Hsueh-Yung; Chen, Ke-Hsin; Yang, Po-Wen; Lu, Christine Y. |
| 國立成功大學 |
2015-07 |
How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?
|
Hsu, Jason C.; Ross-Degnan, Dennis; Wagner, Anita K.; Zhang, Fang; Lu, Christine Y. |
| 國立成功大學 |
2015-04-21 |
Net Clinical Benefit of Oral Anticoagulants: A Multiple Criteria Decision Analysis
|
Hsu, Jason C.; Hsieh, Cheng-Yang; Yang, Yea-Huei Kao; Lu, Christine Y. |
| 國立成功大學 |
2015-02-10 |
The evolution of Taiwan's National Health Insurance drug reimbursement scheme
|
Hsu, Jason C.; Lu, Christine Y. |
| 國立成功大學 |
2014-10 |
Changes in Thiazolidinedione Utilization and Outcomes Following Safety Warning and Risk Evaluation & Mitigation Strategies (REMS) in Taiwan
|
Hsu, Jason C.; Ross-Degnan, Dennis; Cheng, Ching-Lan; Wagner, Anita K.; Zhang, Fang; Yang, Yea-Huei Kao; Liu, Li-Ling; Tai, Hsueh-Yung; Chen, Ke-Hsin; Yang, Po-Wen; Juan, Yi-Chen; Lu, Christine Y. |
| 國立臺灣大學 |
2014 |
Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: An interrupted time series study
|
Hsu, Jason C.; Lu, Christine Y.; Wagner, Anita K.; Chan, K. Arnold; Lai, Mei-Shu; Ross-Degnan, Dennis; 陳建煒; 賴美淑 |
顯示項目 11-16 / 16 (共1頁)
1
每頁顯示[10|25|50]項目
|
